Tumor Response and Patient’s Characteristics
| . | All Patients (n = 52) . | Responders (n = 17) . | % . |
|---|---|---|---|
| Prior lymphoma history | |||
| First relapse | 17 | 7 | 41% |
| Second relapse | 5 | 4 | 80% |
| Primary refractory | 9 | 2 | 22% |
| PD after PR | 12 | 1 | 8% |
| Untreated | 9 | 3 | 33% |
| Histology (REAL classification) | |||
| DLCL | 30 | 11 | 37% |
| MCL | 12 | 4 | 33% |
| Follicular | 1 | 1 | — |
| NOS | 9 | 1 | 11% |
| Prior ABMT | |||
| Yes | 9 | 3 | 33% |
| No | 43 | 14 | 33% |
| Bone marrow involvement | |||
| Yes | 7 | 3 | 43% |
| No | 13 | 2 | 15% |
| Unknown | 32 | 12 | 37% |
| Largest tumor lesion | |||
| <5 cm | 28 | 13 | 46% |
| 5-10 cm | 19 | 4 | 21% |
| ≥10 cm | 5 | 0 | 0% |
| . | All Patients (n = 52) . | Responders (n = 17) . | % . |
|---|---|---|---|
| Prior lymphoma history | |||
| First relapse | 17 | 7 | 41% |
| Second relapse | 5 | 4 | 80% |
| Primary refractory | 9 | 2 | 22% |
| PD after PR | 12 | 1 | 8% |
| Untreated | 9 | 3 | 33% |
| Histology (REAL classification) | |||
| DLCL | 30 | 11 | 37% |
| MCL | 12 | 4 | 33% |
| Follicular | 1 | 1 | — |
| NOS | 9 | 1 | 11% |
| Prior ABMT | |||
| Yes | 9 | 3 | 33% |
| No | 43 | 14 | 33% |
| Bone marrow involvement | |||
| Yes | 7 | 3 | 43% |
| No | 13 | 2 | 15% |
| Unknown | 32 | 12 | 37% |
| Largest tumor lesion | |||
| <5 cm | 28 | 13 | 46% |
| 5-10 cm | 19 | 4 | 21% |
| ≥10 cm | 5 | 0 | 0% |
Abbreviation: NOS, not otherwise specified.